Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04186221 · ClinicalTrials.gov registry record · NA
OCS Liver PROTECT Continued Access Protocol
A NA study of Liver Transplant, sponsored by TransMedics.
- Completed
- Registry status
- NA
- Development phase
- 74
- Enrollment target
- 17
- Study locations
NCT04186221 is a NA study of Liver Transplant that has completed, run by TransMedics. The registered enrollment target is 74 participants, below the 5,454-participant average among 19 other Liver Transplant trials with a reported enrollment target (99% lower). The trial reports 17 study locations across 11 states.
The verdict
NCT04186221, a NA study of Liver Transplant, has completed, sponsored by TransMedics.
- COMPLETED
- Registry status
- NA
- Development phase
- 74 participants
- Enrollment target
- 17
- Study locations
Study Summary
Continued Access Protocol to evaluate the effectiveness of the OCS Liver System to preserve and assess donor livers.
Conditions Studied
Interventions
- DEVICE OCS Liver System
Study Locations (17)
California
- Scripps - La Jolla
- University of California San Diego - La Jolla
- UCSF - San Francisco
Texas
- University of Texas Southwest - Dallas
- Houston Methodist Hospital - Houston
- The University of Texas Health Science Center at San Antonio - San Antonio
New York
- Mount Sinai Hospital - New York
- Montefiore Einstein Center for Transplantation - The Bronx
Virginia
- University of Virginia - Charlottesville
- Virginia Commonwealth University Health System - Richmond
Florida
- Tampa General - Tampa
Maryland
- Johns Hopkins - Baltimore
Massachusetts
- Massachusetts General Hospital - Boston
Michigan
- Henry Ford Hospital - Detroit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2020-02-03 |
| Est. Completion | 2023-02-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04186221
The ClinicalTrials.gov registry entry for NCT04186221 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,454-participant average among 19 other Liver Transplant trials with a reported enrollment target (99% lower). The listed sponsor is TransMedics, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Liver Transplant appearing as the primary indexed condition, and to 1 intervention - of which OCS Liver System is the first listed.
NCT04186221 reports 17 study locations spanning 11 distinct geographic areas - top geographies include California, Texas, New York.
Frequently Asked Questions
What is clinical trial NCT04186221 about?
NCT04186221 is a clinical study titled "OCS Liver PROTECT Continued Access Protocol". Continued Access Protocol to evaluate the effectiveness of the OCS Liver System to preserve and assess donor livers.
What is the current status of trial NCT04186221?
This trial is currently completed. It is a NA study. The enrollment target is 74 participants. The study started on 2020-02-03. Estimated completion is 2023-02-02.
What conditions does trial NCT04186221 study?
This clinical trial studies the following conditions: Liver Transplant.
What interventions are being tested in trial NCT04186221?
The interventions under investigation include: OCS Liver System (DEVICE).
Who is sponsoring clinical trial NCT04186221?
This trial is sponsored by TransMedics, which has 23 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04186221 being conducted?
This trial has 17 study locations across California, Florida, Maryland, Massachusetts, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Liver Transplant
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Auriculo-Nerve Stimulation on Post-Operative Opioid Requirement
RECRUITING · NA
-
Normothermic Machine Perfusion of Steatotic Livers for Expansion of Donor Organ Pool
RECRUITING · NA
-
Text Messaging for Adherence in Adolescent Liver Transplant Recipients
COMPLETED · NA
-
Increasing Activity in Liver Transplant Patients
COMPLETED · NA
-
Expanding Liver Transplant Immunosuppression Minimization Via Everolimus
RECRUITING · Phase 2
-
US National OCS Liver Perfusion (OLP) Registry
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.